CHARLES FALCONER: Open Payments
NPI 1770143430 · MODESTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,185 in 91 payments from 13 companies in 2025. Trend: 2023 $2,000 · 2024 $2,577 · 2025 $2,185
Food & beverage: $2,086Education: $100
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $439 |
| ABBVIE INC. | 16 | $307 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $266 |
| Otsuka America Pharmaceutical, Inc. | 11 | $234 |
| E.R. Squibb & Sons, L.L.C. | 6 | $230 |
| Braeburn Inc. | 5 | $199 |
| Neurocrine BioSciences, Inc. | 2 | $152 |
| Alkermes, Inc. | 5 | $109 |
| Janssen Pharmaceuticals, Inc | 3 | $100 |
| Lundbeck LLC | 3 | $73 |
Products named: VRAYLAR, AUSTEDO XR, CAPLYTA, COBENFY, BRIXADI, REXULTI, INGREZZA, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
